Kopsuvähk kliinilised uuringud osariigis Alaska
7 uuringut haiguse Kopsuvähk jaoks otsivad osalejaid osariigis Alaska.
Linnad osariigis Alaska
Ametlik uuringutekst (inglise keeles)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Fairbanks Memorial Hospital, Fairbanks
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. okt 2026 · NCT04267848Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Anchorage Associates in Radiation Medicine, Anchorage
- Alaska Breast Care and Surgery LLC, Anchorage
- Alaska Oncology and Hematology LLC, Anchorage
- ja veel 3
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 40–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT05334069Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Alaska Oncology and Hematology LLC, Anchorage
- Katmai Oncology Group, Anchorage
- Fairbanks Memorial Hospital, Fairbanks
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT04181060Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Alaska Oncology and Hematology, LLC, Anchorage
VärbamineFaas 2/3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT06712316A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Alaska Oncology and Hematology, Anchorage
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 8. sept 2026 · NCT06793215Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Katmai Oncology Group, Anchorage
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. juuni 2026 · NCT05642572Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Katmai Oncology Group, Anchorage
VärbamineFaas 2/3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 5. mai 2026 · NCT06616584Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.